Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Advancements In GLP-1 Agonist Therapies For Diabetes And Weight Management GLP-1 agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists mimic naturally occurring incretin hormones to slow gastric emptying, increase the feeling of fullness, promote insulin secretion, and inhibit the inappropriate release of glucagon
J Biol Chem 294:10831088
2021;23(S3):4052
Presented for research literature review only Rogers NL et al
US$ 29.45
US$ 25.70
US$ 22.98
US$ 25.00
US$ 28.81
